Alex Owyang

Alex Owyang is a seasoned professional in the field of biomedical research, currently serving as the Director of In Vivo Technologies at Recursion. Prior experience includes significant roles in pharmacology and therapeutics at 23andMe, where Alex held the positions of Director and Senior Scientist. Alex also contributed to Rigel Pharmaceuticals Inc. as a Staff Scientist II and Senior Scientist II, and held research positions at XOMA and DNAX Research Institute as a Senior Scientist and Postdoctoral Fellow, respectively. Academic credentials include a Ph.D. in Immunology from Joan & Sanford I. Weill Medical College of Cornell University and a B.A. in Molecular & Cell Biology from the University of California, Berkeley.